IMPROVEMENTS IN MAJOR CLINICAL EVENTS IN CHILDREN TREATED WITH TRIHEPTANOIN FOR LONG-CHAIN FATTY ACID OXIDATION DISORDERS (LC-FAOD)

被引：0
|
作者：
Ray, Kathryn [1 ]
Pisani, Laura [1 ]
Lu, Xiaoxiao [1 ]
Vockley, Jerry [2 ]
机构：
[1] Ultragenyx Pharmaceut Inc, Novato, CA USA
[2] Univ Pittsburgh, Sch Med, UPMC Childrens Hosp Pittsburgh, Pittsburgh, PA USA
来源：
MOLECULAR GENETICS AND METABOLISM | 2022年 / 135卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
75
引用
收藏
页码：295 / 296
页数：2
相关论文
共 50 条
  • [1] Improvement in left ventricular ejection fraction in patients treated with triheptanoin for Long-chain Fatty Acid Oxidation Disorders (LC-FAOD)
    Ray, Kathryn
    Vockley, Jerry
    Ramirez, Antonio Nino
    Lu, Xiaoxiao
    Gillingham, Melanie
    GENETICS IN MEDICINE, 2022, 24 (03) : S101 - S101
  • [2] MAJOR CLINICAL MANIFESTATIONS AND EVENTS AMONG PATIENTS WITH LONG-CHAIN FATTY ACID OXIDATION DISORDERS (LC-FAOD) IN THE UNITED STATES: REAL-WORLD RESULTS FROM LC-FAOD ODYSSEY
    Yang, E.
    Kruger, E.
    Deering, K.
    Stubbe, C.
    Mace, K.
    Tierney, M.
    Cibelli, E.
    Drozd, D.
    Ross, N.
    Herout, P.
    Shillington, A.
    Thomas, N. A.
    Marsden, D.
    Kritzer, A.
    VALUE IN HEALTH, 2022, 25 (07) : S311 - S312
  • [3] Management and symptoms of people living with long-chain fatty acid oxidation disorders (LC-FAOD) in the United States: Results from LC-FAOD Odyssey Study
    Kruger, E.
    Yang, E.
    Thompson, A.
    Reineking, B.
    MOLECULAR GENETICS AND METABOLISM, 2022, 136 : S15 - S16
  • [4] Major clinical events and healthcare resource use among patients with long-chain fatty acid oxidation disorders in the United States: Results from LC-FAOD Odyssey program
    Yang, Erru
    Kruger, Eliza
    Yin, David
    Mace, Kieran
    Tierney, Meghan
    Liao, Noelle
    Cibelli, Emily
    Drozd, Dan
    Ross, Nathan
    Deering, Kathleen L.
    Herout, Peter
    Harshaw, Qing
    Shillington, Alicia
    Thomas, Nina
    Marsden, Deborah
    Kritzer, Amy
    Vockley, Jerry
    MOLECULAR GENETICS AND METABOLISM, 2024, 142 (01)
  • [5] Triheptanoin for the treatment of Long-Chain Fatty Acid Disorders (LC-FAOD): Final results of an open-label, long-term extension study
    Vockley, Jerry
    Burton, Barbara
    Berry, Gerard
    Longo, Nicola
    Phillips, John
    Sanchez-Valle, Amarilis
    Chapman, Kimberly
    Tanpaiboon, Pranoot
    Grunewald, Stephanie
    Murphy, Elaine
    Lu, Xiaoxiao
    Rahman, Syeda
    Ray, Kathryn
    Ramirez, Antonio Nino
    GENETICS IN MEDICINE, 2022, 24 (03) : S349 - S349
  • [6] SYMPTOMS, TREATMENT EFFECTIVENESS AND QUALITY OF LIFE FOR PATIENTS LIVING WITH LONG-CHAIN FATTY ACID OXIDATION DISORDERS (LC-FAOD) IN THE UNITED STATES: PATIENT AND CAREGIVER REPORTED OUTCOMES FROM LC-FAOD ODYSSEY
    Yang, E.
    Kruger, E.
    Thompson, A.
    Reineking, B.
    VALUE IN HEALTH, 2023, 26 (06) : S354 - S355
  • [7] Clinical outcomes of major clinical events and emergency triheptanoin use in critically ill patients with long-chain fatty acid oxidation disorders
    Enns, Gregory
    Marsden, Deborah
    Ramirez, Antonio Nino
    Bedrosian, Camille
    Reineking, Bridget
    Lu, Xiaoxiao
    Rahman, Syeda
    Vockley, Jerry
    MOLECULAR GENETICS AND METABOLISM, 2021, 132 : S86 - S87
  • [8] Triheptanoin in patients with long-chain fatty acid oxidation disorders: clinical experience in Italy
    Porta, Francesco
    Maiorana, Arianna
    Gragnaniello, Vincenza
    Procopio, Elena
    Gasperini, Serena
    Taurisano, Roberta
    Spada, Marco
    Dionisi-Vici, Carlo
    Burlina, Alberto
    ITALIAN JOURNAL OF PEDIATRICS, 2024, 50 (01)
  • [9] Dietary management and major clinical events in patients with long-chain fatty acid oxidation disorders enrolled in a phase 2 triheptanoin study
    Vockley, Jerry
    Longo, Nicola
    Madden, Megan
    Dwyer, Lauren
    Mu, Yunming
    Chen, Chao-Yin
    Cataldo, Jason
    CLINICAL NUTRITION ESPEN, 2021, 41 : 293 - 298
  • [10] INTERIM RESULTS FROM AN OPEN-LABEL PHASE 2 STUDY TO ASSESS SAFETY AND CLINICAL EFFECTS OF INVESTIGATIONAL UX007 (TRIHEPTANOIN) IN SUBJECTS WITH LONG-CHAIN FATTY ACID OXIDATION DISORDERS (LC-FAOD)
    Vockley, Jerry
    Burton, Barbara
    Berry, Gerard
    Longo, Nicola
    Phillips, John A.
    Sanchez-Valle, Amarilis
    Tanpaiboon, Pranoot
    Grunwald, Stephanie
    Murphy, Elaine
    Bowden, Alexandra
    Cataldo, Jason
    Marsden, Deborah
    Kakkis, Emil
    MOLECULAR GENETICS AND METABOLISM, 2016, 117 (03) : 291 - 291
12345